From Akademikliniken; the Department of Plastic Surgery, University Hospitals Birmingham; and the Department of Plastic Surgery, BG University Hospital Bergmannsheil, Ruhr University Bochum.
Plast Reconstr Surg. 2019 Aug;144(2):326-334. doi: 10.1097/PRS.0000000000005849.
Augmentation mastopexy may be a one- or two-stage procedure. Because of the opposing force vectors in augmentation and in mastopexy, some surgeons advocate a two-stage procedure. The literature appears divided on which operation has a more favorable complication profile. The purpose of this review was to benchmark the outcomes of single-stage augmentation mastopexy against those of a commonly performed aesthetic breast operation (primary breast augmentation).
THE AUTHORS: reviewed electronic patient records of all consecutive female patients who underwent single-stage augmentation mastopexy and primary breast augmentation performed by the first author at our clinic between April of 2009 and May of 2017 with at least a 6-month follow-up. Data from single-stage augmentation mastopexy were benchmarked against the outcomes of primary breast augmentations performed by the same surgeon, for the same period, and at the same clinic.
ONE HUNDRED FOUR: single-stage augmentation mastopexies and 801 primary breast augmentations were performed during this period, with mean follow-up of 15.4 months and 14.0 months, respectively. Augmentation mastopexy patients were significantly more likely to be older, have a higher body mass index, have more children, and were significantly less likely to use oral contraceptives. There was no statistically significant difference in overall complication rate between the two groups.
THE AUTHORS': experience suggests that single-stage augmentation mastopexy has outcomes comparable to those of primary breast augmentation. Smokers were more likely to undergo reoperation because of postoperative complication (seroma), but the rate of implant exchange was not different.
CLINICAL QUESTION/LEVEL OF EVIDENCE: THERAPEUTIC, III.
乳房提升术加隆乳术可以是一期或两期手术。由于隆乳术和乳房提升术的反作用力向量，一些外科医生主张进行两期手术。文献似乎对哪种手术具有更有利的并发症特征存在分歧。本综述的目的是将一期隆乳乳房提升术的结果与一种常见的美容乳房手术（原发性乳房增大术）的结果进行基准比较。
作者回顾了 2009 年 4 月至 2017 年 5 月期间在我们诊所由第一作者为连续女性患者进行的一期隆乳乳房提升术和原发性乳房增大术的电子患者记录，至少有 6 个月的随访。将一期隆乳乳房提升术的数据与同期和同一家诊所由同一位外科医生进行的原发性乳房增大术的结果进行基准比较。
在此期间共进行了 104 例一期隆乳乳房提升术和 801 例原发性乳房增大术，平均随访时间分别为 15.4 个月和 14.0 个月。隆乳乳房提升术患者明显更年长、体重指数更高、有更多的孩子，而且明显较少使用口服避孕药。两组患者的总体并发症发生率无统计学差异。
作者的经验表明，一期隆乳乳房提升术的结果与原发性乳房增大术相似。吸烟者因术后并发症（血清肿）更有可能需要再次手术，但植入物更换率没有差异。
临床问题/证据水平：治疗，III。
